ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction

Luo, Xing; Wang, Yuehong; Zhu, Xinxin; Chen, Yuwu; Xu, Biyi; Bai, Xiaoxuan; Weng, Xiuzhu; Xu, Jinmei; Tao, Yangyang; Yang, Dan; Du, Jie; Lv, Ying; Zhang, Shan; Hu, Sining; Li, Ji; Jia, Haibo*上海交通大学; 哈尔滨医科大学
Redox Biology2024-2DOI: 10.1016/j.redox.2023.102987
7阅读
引用收藏
分享

摘要

Background: Micheliolide (MCL), which is the active metabolite of parthenolide, has demonstrated promising clinical application potential. However, the effects and underlying mechanisms of MCL on atherosclerosis are still unclear. Method: ApoE-/- mice were fed with high fat diet, with or without MCL oral administration, then the plaque area, lipid deposition and collagen content were determined. In vitro, MCL was used to pretreat macrophages combined by ox-LDL, the levels of ferroptosis related proteins, NRF2 activation, mitochondrial function and oxidative stress were detected. Results: MCL administration significantly attenuated atherosclerotic plaque progress, which characteristics with decreased plaque area, less lipid deposition and increased collagen. Compared with HD group, the level of GPX4 and xCT in atherosclerotic root macrophages were increased in MCL group obviously. In vitro experiment demonstrated that MCL increased GPX4 and xCT level, improved mitochondrial function, attenuated oxidative stress and inhibited lipid peroxidation to suppress macrophage ferroptosis induced with ox-LDL. Moreover, MCL inhibited KEAP1/NRF2 complex formation and enhanced NRF2 nucleus translocation, while the protective effect of MCL on macrophage ferroptosis was abolished by NRF2 inhibition. Additionally, molecular docking suggests that MCL may bind to the Arg483 site of KEAP1, which also contributes to KEAP1/NRF2 binding. Furthermore, Transfection Arg483 (KEAP1-R483S) mutant plasmid can abrogate the anti-ferroptosis and anti-oxidative effects of MC in macrophages. KEAP1-R483S mutation also limited the protective effect of MCL on atherosclerosis progress and macrophage ferroptosis in ApoE-/- mice. Conclusion: MCL suppressed atherosclerosis by inhibiting macrophage ferroptosis via activating NRF2 pathway, the related mechanism is through binding to the Arg483 site of KEAP1 competitively.

学科与关键词

关键词
AtherosclerosisMCLFerroptosisKEAP1/NRF2Oxidative stress
相关
加载中…
  • A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
    Luo, Xing; Weng, Xiuzhu; Bao, Xiaoyi; Bai, Xiaoxuan; Lv, Ying; Zhang, Shan; Chen, Yuwu; Zhao, Chen; Zeng, Ming; Huang, Jianxin; Xu, Biyi; Johnson, Thomas W.; White, Stephen J.; Li, Ji*; Jia, Haibo*; Yu, BoRedox Biology, 2022, 57.被引 25
  • IL-37 suppresses macrophage ferroptosis to attenuate diabetic atherosclerosis via the NRF2 pathway
    Xu, Jinmei; Han, Xu; Xia, Nan; Zhao, Qingsong; Cheng, Zhifeng*Experimental and Therapeutic Medicine, 2023, 25(6): 289.被引 2
  • Cigarette tar mediates macrophage ferroptosis in atherosclerosis through the hepcidin/FPN/SLC7A11 signaling pathway
    Bao, Xiaoyi; Luo, Xing; Bai, Xiaoxuan; Lv, Ying; Weng, Xiuzhu; Zhang, Shan; Leng, Yanlong; Huang, Jianxin; Dai, Xinyu; Wang, Ying; Li, Ji; Jia, Haibo*Free Radical Biology and Medicine, 2023, 201: 76-88.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Redox Biology
发表日期
2024-02
卷期
第 69 卷
页码
102987
DOI
10.1016/j.redox.2023.102987
语言
ENGLISH
成果收录
SCIE
资助标注
Key Research and Development Plan of Heilongjiang Science and Technology Department [SC2022ZX06C0072]; National Natural Science Foundation of China [82370464, 82061130223, 82072031, 82200454]; HMU Marshal Initiative Funding [HMUMIF-21016]; Natural Science Foundation of Heilongjiang Province [LH2020H112]; Fund of Key Laboratory of Myocardial Ischemia, Ministry of Education [KF202313, KF202308]

作者

  • L

    Luo, Xing (第一作者)

  • W

    Wang, Yuehong

    shanghai jiao tong univ

查看全部 16 位作者收起作者
  • Z

    Zhu, Xinxin

  • C

    Chen, Yuwu

  • X

    Xu, Biyi

  • B

    Bai, Xiaoxuan

  • W

    Weng, Xiuzhu

  • X

    Xu, Jinmei

    harbin med univ · 2

  • T

    Tao, Yangyang

    2 · harbin med univ

  • Y

    Yang, Dan

    shanghai jiao tong univ · harbin med univ

  • D

    Du, Jie

    2 · harbin med univ

  • L

    Lv, Ying

    2 · harbin med univ

  • Z

    Zhang, Shan

    2 · harbin med univ

  • H

    Hu, Sining

    2 · harbin med univ

  • L

    Li, Ji

    2 · harbin med univ

  • J

    Jia, Haibo (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417